Fanying Meng
9Patents
4h-index
26Co-inventors
53Inventor score
Filing activity: May 1, 2001 → Dec 20, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6506739B1 | Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents | Chemistry; Metallurgy | 13 | Expired |
| US7297696B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 9 | Expired |
| US6962926B2 | Antagonist of MCP-1 function, and compositions and methods of use thereof | Human Necessities | 9 | Expired |
| US6670364B2 | Antagonists of MCP-1 function and methods of use thereof | Human Necessities | 6 | Expired |
| US6809113B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US6677365B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US9254299B2 | Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer | Human Necessities | 1 | Active |
| US6998407B2 | Antagonists of MCP-1 function and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US6992086B2 | Antagonists of MCP-1 function and methods of use thereof | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.